AP NEWS
Related topics

Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion

January 3, 2019

NEW YORK (AP) — Bristol-Myers Squibb to buy Celgene in a cash and stock deal worth $74 billion.

AP RADIO
Update hourly